The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Self-citationGranules of the Human Neutrophilic Polymorphonuclear Leukocyte
Borregaard, N., & Cowland, J. B. (1997) · Blood · doi:10.1182/blood.v89.10.3503 · Cited by 1,522
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Matrix metalloproteinases and metastasis
Kleiner, D. E., & Stetler-Stevenson, W. G. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051097 · Cited by 701
Carmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679
Self-citationUrokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaître, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S., Lupu, F., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-439 · Cited by 661
Self-citationZhang, B., Ye, S., Herrmann, S.-M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1788 · Cited by 611
Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M., & Ross, R. (1996) · Cell · doi:10.1016/s0092-8674(00)81801-2 · Cited by 515
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
Linton, M. F., Atkinson, J. B., & Fazio, S. (1995) · Science · doi:10.1126/science.7863332 · Cited by 478
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
Chapman, H. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80126-3 · Cited by 464
Cited by
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Self-citationMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Self-citationHow Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., & Itescu, S. (2001) · Nature Medicine · doi:10.1038/86498 · Cited by 2,540
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
The inflammatory response in myocardial infarction
Frangogiannis, N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00434-5 · Cited by 2,011
Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., Semprun-Prieto, L., Delafontaine, P., & Prockop, D. J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.003 · Cited by 1,898
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Self-citationuPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Self-citationSpinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Molecular mechanisms of blood vessel growth
Conway, E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00281-9 · Cited by 1,030
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
Fan, D., Takawale, A., Lee, J., & Kassiri, Z. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-15 · Cited by 814
Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L. E., Schoen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Platelets, inflammation and tissue regeneration
Nurden, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0720 · Cited by 791
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 773
Self-citationProgress in matrix metalloproteinase research
MURPHY, G., & NAGASE, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 759
Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., Weber, C., Soehnlein, O., & Steffens, S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw002 · Cited by 727
Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 726
THE CARDIAC FIBROBLAST: Therapeutic Target in Myocardial Remodeling and Failure
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095802 · Cited by 647
Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease
Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E., & Lindsey, M. L. (2013) · Physiology · doi:10.1152/physiol.00029.2013 · Cited by 635
Jugdutt, B. I. (2003) · Circulation · doi:10.1161/01.cir.0000085658.98621.49 · Cited by 629
Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Self-citationNoyan-Ashraf, M. H., Momen, M. A., Ban, K., Sadi, A.-M., Zhou, Y.-Q., Riazi, A. M., Baggio, L. L., Henkelman, R. M., Husain, M., & Drucker, D. J. (2009) · Diabetes · doi:10.2337/db08-1193 · Cited by 575
“* ** ** Untreated Liraglutide EX(9-39) Liraglutide +EX(9-39) Forskolin 0 10 20 30 40 50 60”
BackgroundIRF3 and type I interferons fuel a fatal response to myocardial infarction
King, K. R., Aguirre, A. D., Ye, Y.-X., Sun, Y., Roh, J. D., Ng, R. P., Kohler, R. H., Arlauckas, S. P., Iwamoto, Y., Savol, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4428 · Cited by 570
Gelatinase B functions as regulator and effector in leukocyte biology
Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., & Van Damme, J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.851 · Cited by 553
Kempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Rossaint, J., Bolomini-Vittori, M., Korf-Klingebiel, M., Napp, L. C., Hansen, B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2354 · Cited by 518
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Manabe, I., Shindo, T., & Nagai, R. (2002) · Circulation Research · doi:10.1161/01.res.0000046452.67724.b8 · Cited by 512
Periostin is essential for cardiac healingafter acute myocardial infarction
Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., Saito, M., Fukuda, K., Nishiyama, T., Kitajima, S., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071297 · Cited by 461
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
Gough, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25074 · Cited by 452
Li, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00003-1 · Cited by 434
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046292 · Cited by 426
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
van Hinsbergh, V. W. M., & Koolwijk, P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm102 · Cited by 420
Bioactive Glass Stimulates the Secretion of Angiogenic Growth Factors and Angiogenesis in Vitro
Day, R. M. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.768 · Cited by 389
Pericellular Proteases in Angiogenesis and Vasculogenesis
van Hinsbergh, V. W. M., Engelse, M. A., & Quax, P. H. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209518.58252.17 · Cited by 389
Understanding the biology of angiogenesis: Review of the most important molecular mechanisms
Otrock, Z. K., Mahfouz, R. A. R., Makarem, J. A., & Shamseddine, A. I. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2007.04.001 · Cited by 386
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C., Tincey, S., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63154-9 · Cited by 382
Matrix metalloproteinases in lung biology
Parks, W. C., & Shapiro, S. D. (2000) · Respiratory Research · doi:10.1186/rr33 · Cited by 380
Self-citationNeri, M., Riezzo, I., Pascale, N., Pomara, C., & Turillazzi, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/7018393 · Cited by 379
α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations
Díaz-Ramos, À., Roig-Borrellas, A., García-Melero, A., & López-Alemany, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/156795 · Cited by 373
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/80430 · Cited by 370
Self-citationMatrix Metalloproteinase Inhibitor Development and the Remodeling of Drug Discovery
Peterson, J. T. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011395.11179.af · Cited by 370
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357
Self-citationRole of Fibrin Matrix in Angiogenesis
van HINSBERGH, V. W. M., COLLEN, A., & KOOLWIJK, P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03526.x · Cited by 339
Matsumura, S.-I., Iwanaga, S., Mochizuki, S., Okamoto, H., Ogawa, S., & Okada, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522304 · Cited by 339
Heymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J.-L., Cohen-Tervaert, J. W., Drexler, H., Filippatos, G., Felix, S. B., Gullestad, L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 323
Self-citationHayashidani, S., Tsutsui, H., Ikeuchi, M., Shiomi, T., Matsusaka, H., Kubota, T., Imanaka-Yoshida, K., Itoh, T., & Takeshita, A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00207.2003 · Cited by 315
Pleiotropic functions of plasminogen activator inhibitor-1
LIJNEN, H. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00827.x · Cited by 312
Lo, E. H., Wang, X., & Cuzner, M. L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10270 · Cited by 310
Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts
Frangogiannis, N. G., Ren, G., Dewald, O., Zymek, P., Haudek, S., Koerting, A., Winkelmann, K., Michael, L. H., Lawler, J., & Entman, M. L. (2005) · Circulation · doi:10.1161/circulationaha.104.510354 · Cited by 308
Luttun, A., Lutgens, E., Manderveld, A., Maris, K., Collen, D., Carmeliet, P., & Moons, L. (2004) · Circulation · doi:10.1161/01.cir.0000121728.14930.de · Cited by 308
Self-citationDobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090759 · Cited by 301
Peterson, J. T., Hallak, H., Johnson, L., Li, H., O’Brien, P. M., Sliskovic, D. R., Bocan, T. M. A., Coker, M. L., Etoh, T., & Spinale, F. G. (2001) · Circulation · doi:10.1161/01.cir.103.18.2303 · Cited by 301
Healing after myocardial infarction
ERTL, G., & FRANTZ, S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.011 · Cited by 300
Kraehenbuehl, T. P., Zammaretti, P., Van der Vlies, A. J., Schoenmakers, R. G., Lutolf, M. P., Jaconi, M. E., & Hubbell, J. A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.03.016 · Cited by 299
Peterson, J. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00029-8 · Cited by 298
The Mechanistic Basis of Infarct Healing
Frangogiannis, N. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1907 · Cited by 288
Matrix Metalloproteinases in Myocardial Infarction and Heart Failure
DeLeon-Pennell, K. Y., Meschiari, C. A., Jung, M., & Lindsey, M. L. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.001 · Cited by 287
Myofibroblast and Endothelial Cell Proliferation during Murine Myocardial Infarct Repair
Virag, J. I., & Murry, C. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63598-5 · Cited by 287
Cathepsin L is required for endothelial progenitor cell–induced neovascularization
Urbich, C., Heeschen, C., Aicher, A., Sasaki, K.-I., Bruhl, T., Farhadi, M. R., Vajkoczy, P., Hofmann, W. K., Peters, C., Pennacchio, L. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1182 · Cited by 284
Halade, G. V., Jin, Y.-F., & Lindsey, M. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.009 · Cited by 281
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
Minatoguchi, S., Takemura, G., Chen, X.-H., Wang, N., Uno, Y., Koda, M., Arai, M., Misao, Y., Lu, C., Suzuki, K., et al. (2004) · Circulation · doi:10.1161/01.cir.0000129770.93985.3e · Cited by 276
Sun, M., Dawood, F., Wen, W.-H., Chen, M., Dixon, I., Kirshenbaum, L. A., & Liu, P. P. (2004) · Circulation · doi:10.1161/01.cir.0000147233.10318.23 · Cited by 275
Shiomi, T., Lemaître, V., D'Armiento, J., & Okada, Y. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02547.x · Cited by 274
Physiological Implications of Myocardial Scar Structure
Richardson, W. J., Clarke, S. A., Quinn, T. A., & Holmes, J. W. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140067 · Cited by 268
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 265
VANHOUTTE, D., SCHELLINGS, M., PINTO, Y., & HEYMANS, S. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.002 · Cited by 261
Self-citationThe Macrophage in Cardiac Homeostasis and Disease
Lavine, K. J., Pinto, A. R., Epelman, S., Kopecky, B. J., Clemente-Casares, X., Godwin, J., Rosenthal, N., & Kovacic, J. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2149 · Cited by 234
YAMAMOTO, K., TAKESHITA, K., KOJIMA, T., TAKAMATSU, J., & SAITO, H. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.013 · Cited by 214
Feng, W., Li, W., Liu, W., Wang, F., Li, Y., & Yan, W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.06.001 · Cited by 139
Cardiac remodeling and failure
Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R.-K. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.01.005 · Cited by 120
Hansson, J., Vasan, R. S., Ärnlöv, J., Ingelsson, E., Lind, L., Larsson, A., Michaëlsson, K., & Sundström, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016185 · Cited by 103
(2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.9.2553 · Cited by 44
Metadata
- Authors
- Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G. D., Cleutjens, J. P. M., Shipley, M., Angellilo, A., Levi, M., Nüβe, O., Baker, A., Keshet, E., Lupu, F., Herbert, J.-M., Smits, J. F. M., Shapiro, S. D., Baes, M., Borgers, M., Collen, D., Daemen, M. J. A. P., & Carmeliet, P.
- Venue
- Nature Medicine
- Published
- 1999-10
- Volume
- 5
- Issue
- 10
- Pages
- 1135-1142
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1557058411
- Cited by
- 794
- References
- 31
- FWCI
- 28.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.